Evaluation of an Automated Smartphone-based Digital Auscultation

Status Completed

Clinical Trial Summary

This pilot study is to investigate the feasibility of obtaining medical grade audio phonocardiogram (PCG) recordings using a smartphone-based auscultation device in the first step. The ability to determine Valvular Heart Disease (VHD) (i.e., presence or absence of cardiac murmurs) using novel handheld CAA-devices shall be analyzed and first data on a smartphone-based auscultation in a hospital setting shall be collected. In further studies, the data provided from this study can be used to investigate the potential diagnostic use of such devices in the ambulatory and stationary care scenarios.

Clinical Trial Description

Cardiac auscultation is considered to be highly subjective with substantial varying sensitivities and specificities in regard of the practitioners' expertise. Computer-assisted auscultation (CAA) aims to provide increased objectivity. CAA makes auscultation procedure less operator-dependent, approximate inter-examiner differences and may reduce uncertainties in the course of the examination. With the introduction of modern Machine Learning software libraries and ever-growing computational resources CAA has advanced significantly and is now able to classify heart sounds and murmurs into normal and abnormal, using complex spectro-temporal signal processing techniques and neural network pathways. CAA has simultaneously made the shift from the deployment on computers to consumer smartphones. A benefit of CAA can be expected from the smartphone alone in terms of cost, application range, the clinical validity of such algorithms should now be measured in this pilot study. This pilot study is to investigate the feasibility of obtaining medical grade audio phonocardiogram (PCG) recordings using a smartphone-based auscultation device in the first step. In further studies, the data provided from this study can be used to investigate the potential diagnostic use of such devices in the ambulatory and stationary care scenarios. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05325723
Study type	Observational
Source	University Hospital, Basel, Switzerland
Contact
Status	Completed
Phase
Start date	August 30, 2022
Completion date	July 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05654272` - Development of CIRC Technologies
Completed	`NCT02241109` - Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity	N/A
Completed	`NCT03799133` - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery	N/A
Completed	`NCT01676727` - ADVANCE Direct Aortic Study
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT00721136` - Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation	N/A
Recruiting	`NCT05044338` - Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease
Recruiting	`NCT05014750` - Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
Recruiting	`NCT05015829` - Diagnostic Impact of Low-dose Dobutamine Echocardiography in Low-flow Low-gradient Aortic Stenosis
Recruiting	`NCT05078619` - Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation	N/A
Recruiting	`NCT06307262` - European Registry of Transcatheter Repair for Tricuspid Regurgitation
Completed	`NCT01624870` - CoreValve Advance-II Study: Prospective International Post-market Study
Recruiting	`NCT06077201` - Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions	N/A
Completed	`NCT05708690` - Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery	Phase 4
Recruiting	`NCT03797820` - Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly（Mrs AVS）
Recruiting	`NCT06077721` - Milrinone on Right Ventricular Strain in Cardiac Surgery
Not yet recruiting	`NCT04632914` - Effect of Trunk Stabilizing Exercises on Patients With Median Sternotomy After Heart Valve Surgery	N/A
Completed	`NCT01477151` - Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery	Phase 4
Terminated	`NCT03590730` - Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy
Recruiting	`NCT06204783` - Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions (PLUTO-II)

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of an Automated Smartphone-based Digital Auscultation Application for Detecting Abnormal Heart Sounds Using Deep Learning Techniques — AVDA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms